|1.||Mitsumori, Kunitoshi: 3 articles (02/2010 - 08/2003)|
|2.||Jin, Meilan: 2 articles (02/2010 - 01/2006)|
|3.||Okamura, Miwa: 2 articles (01/2006 - 08/2003)|
|4.||Kashida, Yoko: 2 articles (01/2006 - 08/2003)|
|5.||Moto, Mitsuyoshi: 2 articles (01/2006 - 08/2003)|
|6.||Saegusa, Yukie: 1 article (02/2010)|
|7.||Nishimura, Jihei: 1 article (02/2010)|
|8.||Shibutani, Makoto: 1 article (02/2010)|
|9.||Kemmochi, Sayaka: 1 article (02/2010)|
|10.||Dewa, Yasuaki: 1 article (02/2010)|
|1.||Wounds and Injuries (Trauma)
02/01/2010 - "The threshold dose for liver tumor promoting effects of dicyclanil in ICR mice."
01/01/2006 - "Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice."
02/01/2010 - "To determine the threshold dose of dicyclanil (DC) that induces hepatocellular tumor-promoting effects associated with reactive oxygen species (ROS) generation via their metabolic pathways, partial hepatectomized ICR male mice were fed diets containing 0, 187.5, 375 or 750 ppm DC after an intraperitoneal injection of N-diethylnitrosamine (DEN) to initiate hepatocarcinogenesis. "
|3.||Body Weight (Weight, Body)
08/01/2003 - "In addition, to investigate its possible initiation activity, partially hepatectomized male F344 rats given a single oral administration of 75 mg/kg body weight of dicyclanil were examined by a short-term liver initiation assay. "
08/01/2003 - "In order to clarify the in vivo genotoxicity of dicyclanil with the potential of hepatocarcinogenicity, the stomach, colon, liver, kidney, urinary bladder, lung, brain and bone marrow of male ddY mice given a single oral administration of 100 and 200 mg/kg body weight of dicyclanil were evaluated in an alkaline single-cell gel electrophoresis (comet) assay. "
|1.||Reactive Oxygen Species (Oxygen Radicals)